Miller, Ashley M <br/><br/>
Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 389-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1524-9557 
<br/><br/><label>Standard No.: </label>10.1097/01.cji.0000165353.19171.41  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigen Presentation--immunology<br/>Antigens, CD--analysis<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Coculture Techniques<br/>Dendritic Cells--immunology<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Immunity, Cellular--immunology<br/>Immunophenotyping<br/>Interferon-gamma--metabolism<br/>Interleukin-10--metabolism<br/>Interleukins--metabolism<br/>Lymphocyte Activation--immunology<br/>Male<br/>Monitoring, Immunologic<br/>Peptide Fragments--immunology<br/>Prostate-Specific Antigen--genetics<br/>Prostatic Neoplasms--drug therapy<br/>T-Lymphocytes--immunology<br/>Vaccines, DNA--administration & dosage